Tenax Therapeutics (TENX) Asset Utilization Ratio (2011 - 2013)
Tenax Therapeutics recorded quarterly Asset Utilization Ratio of 0.38 in Q2 2013, up 14.6% quarter-over-quarter from 0.33 in Q1 2013, and up 438.2% year-over-year from 0.07 in Q2 2012.
Tenax Therapeutics' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.38 for Q2 2013.
- In Q2 2013, Asset Utilization Ratio rose 438.2% year-over-year to 0.38; the TTM figure through Apr 2013 stood at 0.38 (up 438.2% YoY), while the FY2013 annual figure was 0.33, up 265.3% from the prior year.
- Asset Utilization Ratio came in at 0.38 for Q2 2013 at Tenax Therapeutics, up from 0.33 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.38 in Q2 2013 to a low of 0.03 in Q3 2011.
- A 3-year average of 0.16 and a median of 0.1 in 2012 frame the typical range for Asset Utilization Ratio.
- On a YoY basis, Asset Utilization Ratio climbed as much as 562.67% in 2012 and fell as far as 381.74% in 2012.
- Tenax Therapeutics' Asset Utilization Ratio stood at 0.04 in 2011, then jumped by 562.67% to 0.24 in 2012, then jumped by 61.99% to 0.38 in 2013.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.38, 0.33, and 0.24 for Q2 2013, Q1 2013, and Q4 2012 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2013 | 0.38 |
| Jan 31, 2013 | 0.33 |
| Oct 31, 2012 | 0.24 |
| Jul 31, 2012 | 0.13 |
| Apr 30, 2012 | 0.07 |
| Jan 31, 2012 | 0.06 |
| Oct 31, 2011 | 0.04 |
| Jul 31, 2011 | 0.03 |